Abstract
BackgroundThe analysis of interleukin-6 serum levels in patients with ankylosing spondylitis (AS) have indicated that IL-6 might be a proinflammatory cytokine in AS patients. However, a placebo-controlled trail using Tocilizumab...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have